Antiretroviral-naïve HIV-infected patients had lower bone formation markers than HIV-uninfected adults

References

• Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P., Zingman, B. S., & Horberg, M. A. (2014). Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine association of the Infectious diseases Society of America. Clinical Infectious Diseases, 58(1), 1–10. doi: 10.1093/cid/cit757
   PubMed Web of Science ®Google Scholar
• Amorosa, V., & Tebas, P. (2006). Bone disease and HIV infection. Clinical Infectious Diseases, 42(1), 108–114. doi: 10.1086/498511
   PubMed Web of Science ®Google Scholar
• Arnsten, J. H., Freeman, R., Howard, A. A., Floris-Moore, M., Santoro, N., & Schoenbaum, E. E. (2006). HIV infection and bone mineral density in middle-aged women. Clinical Infectious Diseases, 42(7), 1014–1020. doi: 10.1086/501015
   PubMed Web of Science ®Google Scholar
• Battalora, L. A., Young, B., & Overton, E. T. (2014). Bones, fractures, antiretroviral therapy and HIV. Current Infectious Disease Reports, 16(2), 393. doi: 10.1007/s11908-014-0393-1
   PubMed Web of Science ®Google Scholar
• Brown, T. T., Hoy, J., Borderi, M., Guaraldi, G., Renjifo, B., Vescini, F., … Powderly, W. G. (2015). Recommendations for evaluation and management of bone disease in HIV. Clinical Infectious Diseases, 60(8), 1242–1251. doi: 10.1093/cid/civ010
   PubMed Web of Science ®Google Scholar
• Brown, T. T., & McComsey, G. A. (2010). Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antiviral Therapy, 15(3), 425–429. doi: 10.3851/IMP1502
   PubMed Web of Science ®Google Scholar
• Brown, T. T., McComsey, G. A., King, M. S., Qaqish, R. B., Bernstein, B. M., & da Silva, B. A. (2009). Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. JAIDS Journal of Acquired Immune Deficiency Syndromes, 51(5), 554–561. doi: 10.1097/QAI.0b013e3181adce44
   PubMed Web of Science ®Google Scholar
• Brown, T. T., & Qaqish, R. B. (2006). Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review. Aids (london, England), 20(17), 2165–2174. doi: 10.1097/QAD.0b013e32801022eb
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2017). National health and nutrition examination survey. Retrieved from https://www.cdc.gov/nchs/nhanes/index.htm
   Google Scholar
• Chailurkit, L. O., Aekplakorn, W., & Ongphiphadhanakul, B. (2011). Regional variation and determinants of vitamin D status in sunshine-abundant Thailand. BMC Public Health, 11, 853. doi: 10.1186/1471-2458-11-853
   PubMed Web of Science ®Google Scholar
• Compston, J. (2014). Osteoporosis and fracture risk associated with HIV infection and treatment. Endocrinology and Metabolism Clinics of North America, 43(3), 769–780. doi: 10.1016/j.ecl.2014.05.001
   PubMed Web of Science ®Google Scholar
• Cotter, A. G., & Powderly, W. G. (2011). Endocrine complications of human immunodeficiency virus infection: Hypogonadism, bone disease and tenofovir-related toxicity. Best Practice & Research Clinical Endocrinology & Metabolism, 25(3), 501–515. doi: 10.1016/j.beem.2010.11.003
   PubMed Web of Science ®Google Scholar
• Dolan, S. E., Kanter, J. R., & Grinspoon, S. (2006). Longitudinal analysis of bone density in human immunodeficiency virus-infected women. The Journal of Clinical Endocrinology & Metabolism, 91(8), 2938–2945. doi: 10.1210/jc.2006-0127
   PubMed Web of Science ®Google Scholar
• European AIDS Clinical Society. (2017). European AIDS clinical society guidelines Version 8.2 - January 2017. Retrieved from http://www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html
   Google Scholar
• Fakruddin, J. M., & Laurence, J. (2003). HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk. Journal of Biological Chemistry, 278(48), 48251–48258. doi: 10.1074/jbc.M304676200
   PubMed Web of Science ®Google Scholar
• Fakruddin, J. M., & Laurence, J. (2005). HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity. Archives of Virology, 150(1), 67–78. doi: 10.1007/s00705-004-0395-7
   PubMed Web of Science ®Google Scholar
• Feizabad, E., Hossein-nezhad, A., Maghbooli, Z., Ramezani, M., Hashemian, R., & Moattari, S. (2017). Impact of air pollution on vitamin D deficiency and bone health in adolescents. Archives of Osteoporosis, 12(1), 34. doi: 10.1007/s11657-017-0323-6
   PubMed Web of Science ®Google Scholar
• Guerri-Fernandez, R., Vestergaard, P., Carbonell, C., Knobel, H., Aviles, F. F., Castro, A. S., … Diez-Perez, A. (2013). HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: A population-based cohort study. Journal of Bone and Mineral Research, 28(6), 1259–1263. doi: 10.1002/jbmr.1874
   PubMed Web of Science ®Google Scholar
• Gvozdovskyy, I., Orlova, T., Salkova, E., Terenetskaya, I., & Milinevsky, G. (2005). Ozone and solar UV-B radiation: Monitoring of the vitamin D synthetic capacity of sunlight in Kiev and Antarctica. International Journal of Remote Sensing, 26(16), 3555–3559. doi: 10.1080/01431160500076863
   Web of Science ®Google Scholar
• Hamill, M. M., Ward, K. A., Pettifor, J. M., Norris, S. A., & Prentice, A. (2013). Bone mass, body composition and vitamin D status of ARV-naive, urban, black South African women with HIV infection, stratified by CD(4) count. Osteoporosis International, 24(11), 2855–2861. doi: 10.1007/s00198-013-2373-y
   PubMed Web of Science ®Google Scholar
• Hernandez-Vallejo, S. J., Beaupere, C., Larghero, J., Capeau, J., & Lagathu, C. (2013). HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: Beneficial effect of pravastatin. Aging Cell, 12(6), 955–965. doi: 10.1111/acel.12119
   PubMed Web of Science ®Google Scholar
• Holick, M. F. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266–281. doi: 10.1056/NEJMra070553
   PubMed Web of Science ®Google Scholar
• Hosseinpanah, F., Heibatollahi, M., Moghbel, N., Asefzade, S., & Azizi, F. (2010). The effects of air pollution on vitamin D status in healthy women: A cross sectional study. BMC Public Health, 10, 519. doi: 10.1186/1471-2458-10-519
   PubMed Web of Science ®Google Scholar
• Kanis, J. A., Melton, L. J., III, Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994). The diagnosis of osteoporosis. Journal of Bone and Mineral Research, 9(8), 1137–1141. doi: 10.1002/jbmr.5650090802
   PubMed Web of Science ®Google Scholar
• Lo Re, V., Lynn, K., Stumm, E. R., Long, J., Nezamzadeh, M. S., Baker, J. F., … Leonard, M. B. (2015). Structural bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected women. Journal of Infectious Diseases, 212(6), 924–933. doi: 10.1093/infdis/jiv147
   PubMed Web of Science ®Google Scholar
• Mansueto, P., Seidita, A., Vitale, G., Gangemi, S., Iaria, C., & Cascio, A. (2015). Vitamin D deficiency in HIV infection: Not only a bone disorder. BioMed Research International, 2015, 1–18. doi: 10.1155/2015/735615
   Web of Science ®Google Scholar
• Masyeni, S., Utama, S., Somia, A., Widiana, R., & Merati, T. P. (2013). Factors influencing bone mineral density in ARV-naive patients at Sanglah Hospital, Bali. Acta Medica Indonesiana, 45(3), 175–179.
   PubMedGoogle Scholar
• McComsey, G. A., Tebas, P., Shane, E., Yin, M. T., Overton, E. T., Huang, J. S., … Brown, T. T. (2010). Bone disease in HIV infection: A practical review and recommendations for HIV care providers. Clinical Infectious Diseases, 51(8), 937–946. doi: 10.1086/656412
   PubMed Web of Science ®Google Scholar
• Mdodo, R., Frazier, E. L., Dube, S. R., Mattson, C. L., Sutton, M. Y., Brooks, J. T., & Skarbinski, J. (2015). Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: Cross-sectional surveys. Annals of Internal Medicine, 162(5), 335–344. doi: 10.7326/M14-0954
   PubMed Web of Science ®Google Scholar
• Mondy, K., & Tebas, P. (2003). Emerging bone problems in patients infected with human immunodeficiency virus. Clinical Infectious Diseases, 36(Suppl 2), S101–S105. doi: 10.1086/367566
   PubMedGoogle Scholar
• Mondy, K., Yarasheski, K., Powderly, W. G., Whyte, M., Claxton, S., DeMarco, D., … Tebas, P. (2003). Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clinical Infectious Diseases, 36(4), 482–490. doi: 10.1086/367569
   PubMed Web of Science ®Google Scholar
• Pinto Neto, L. F., Ragi-Eis, S., Vieira, N. F., Soprani, M., Neves, M. B., Ribeiro-Rodrigues, R., & Miranda, A. E. (2011). Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population. Journal of Clinical Densitometry, 14(4), 434–439. doi: 10.1016/j.jocd.2011.06.004
   PubMed Web of Science ®Google Scholar
• Prieto-Alhambra, D., Guerri-Fernandez, R., De Vries, F., Lalmohamed, A., Bazelier, M., Starup-Linde, J., … Vestergaard, P. (2014). HIV infection and its association with an excess risk of clinical fractures: A nationwide case-control study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 66(1), 90–95. doi: 10.1097/QAI.0000000000000112
   PubMed Web of Science ®Google Scholar
• Rietschel, P., Corcoran, C., Stanley, T., Basgoz, N., Klibanski, A., & Grinspoon, S. (2000). Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clinical Infectious Diseases, 31(5), 1240–1244. doi: 10.1086/317457
   PubMed Web of Science ®Google Scholar
• Sambrook, P. (2007). Tumour necrosis factor blockade and the risk of osteoporosis: Back to the future. Arthritis Research & Therapy, 9(4), 107. doi: 10.1186/ar2277
   PubMed Web of Science ®Google Scholar
• Shahar, E., Segal, E., Rozen, G. S., Shen-Orr, Z., Hassoun, G., Kedem, E., … Ish-Shalom, S. (2013). Vitamin D status in young HIV infected women of various ethnic origins: Incidence of vitamin D deficiency and possible impact on bone density. Clinical Nutrition, 32(1), 83–87. doi: 10.1016/j.clnu.2012.05.022
   PubMed Web of Science ®Google Scholar
• Shiau, S., Broun, E. C., Arpadi, S. M., & Yin, M. T. (2013). Incident fractures in HIV-infected individuals: A systematic review and meta-analysis. Aids (london, England), 27(12), 1949–1957. doi: 10.1097/QAD.0b013e328361d241
   PubMed Web of Science ®Google Scholar
• Triant, V. A., Brown, T. T., Lee, H., & Grinspoon, S. K. (2008). Fracture prevalence among human immunodeficiency virus (HIV)-InfectedVersusNon-HIV-infected patients in a large U.S. healthcare system. The Journal of Clinical Endocrinology & Metabolism, 93(9), 3499–3504. doi: 10.1210/jc.2008-0828
   PubMed Web of Science ®Google Scholar
• Van Den Bout-Van Den Beukel, C. J., Fievez, L., Michels, M., Sweep, F. C., Hermus, A. R., Bosch, M. E., … Van Der Ven, A. J. (2008). Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: Effects of antiretroviral therapy. AIDS Research and Human Retroviruses, 24(11), 1375–1382. doi: 10.1089/aid.2008.0058
   PubMed Web of Science ®Google Scholar
• Vikulina, T., Fan, X., Yamaguchi, M., Roser-Page, S., Zayzafoon, M., Guidot, D. M., … Weitzmann, M. N. (2010). Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats. Proceedings of the National Academy of Sciences, 107(31), 13848–13853. doi: 10.1073/pnas.1003020107
   PubMed Web of Science ®Google Scholar
• Wang, Q, Liu, J, Ding, H, Geng, W, Xu, J, Guo, X., … H, S. (2015). Reduced bone mineral density among ART-naive male patients with HIV in China. Future Virology., 10, 827–833.
   Web of Science ®Google Scholar
• Welz, T., Childs, K., Ibrahim, F., Poulton, M., Taylor, C. B., Moniz, C. F., & Post, F. A. (2010). Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. Aids (london, England), 24(12), 1923–1928. doi: 10.1097/QAD.0b013e32833c3281
   PubMed Web of Science ®Google Scholar
• Wunder, D. M., Bersinger, N. A., Fux, C. A., Mueller, N. J., Hirschel, B., Cavassini, M., … Furrer, H. (2007). Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antiviral Therapy, 12(2), 261–265.
   PubMed Web of Science ®Google Scholar